Multiple sclerosis treatment

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/683 (2006.01) A61K 9/127 (2006.01) A61K 31/685 (2006.01) A61K 47/46 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2578248

Symptoms, including biochemical correlates, of multiple sclerosis (MS) in a mammal are beneficially affected by administering to the mammal small doses of bodies, such as liposomes, of a size resembling that of mammalian cells, the bodies having phosphate glycerol head groups presented exteriorly on their surfaces. Preferred are liposomes comprised of 50-100% phosphatidylglycerol, with the phospho glycerol headgroups thereof exteriorly presented.

Traitement de symptômes, y compris leur corrélation biochimique, de la sclérose en plaques (MS) chez un mammifère, consistant à administrer à ce dernier de petites doses de substances, telles que des liposomes, d'une dimension analogue à celle de cellules mammifères, ces substances comportant des groupes principaux de glycérol phosphaté à l'extérieur de leurs surfaces. Les liposomes préférés sont composés de 50-100 % de phosphatidylglycérol, les groupes principaux de phosphoglycérol de ces liposomes étant situés à l'extérieur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Multiple sclerosis treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multiple sclerosis treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple sclerosis treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1829885

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.